The new generation of antipsychotic drugs

C. A. Tamminga; A. C. Lahti

doi:10.1097/00004850-199605002-00012

The new generation of antipsychotic drugs

C. A. Tamminga, A. C. Lahti

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

New neuroleptic drugs are being developed for the treatment of schizophrenia and other psychoses. Clozapine and risperidone are available for general use. Sertindole and olanzapine are nearing release. Seroquel and ziprazidone are in the final stages of study. This generation of drugs will provide advantages in the area of lower motor side effects and probably in improved negative symptom treatment.

Original language	English (US)
Pages (from-to)	73-76
Number of pages	4
Journal	International Clinical Psychopharmacology
Volume	11
Issue number	SUPPL. 2
DOIs	https://doi.org/10.1097/00004850-199605002-00012
State	Published - 1996

Keywords

Clinical response
Neuroleptics
New antipsychotics
Olanzapine
Seroquel
Sertindole
Ziprazidone

ASJC Scopus subject areas

Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1097/00004850-199605002-00012

Cite this

@article{c6045e5c509e40308755d732a9ce36d9,

title = "The new generation of antipsychotic drugs",

abstract = "New neuroleptic drugs are being developed for the treatment of schizophrenia and other psychoses. Clozapine and risperidone are available for general use. Sertindole and olanzapine are nearing release. Seroquel and ziprazidone are in the final stages of study. This generation of drugs will provide advantages in the area of lower motor side effects and probably in improved negative symptom treatment.",

keywords = "Clinical response, Neuroleptics, New antipsychotics, Olanzapine, Seroquel, Sertindole, Ziprazidone",

author = "Tamminga, {C. A.} and Lahti, {A. C.}",

year = "1996",

doi = "10.1097/00004850-199605002-00012",

language = "English (US)",

volume = "11",

pages = "73--76",

journal = "International Clinical Psychopharmacology",

issn = "0268-1315",

publisher = "Lippincott Williams and Wilkins",

number = "SUPPL. 2",

}

TY - JOUR

T1 - The new generation of antipsychotic drugs

AU - Tamminga, C. A.

AU - Lahti, A. C.

PY - 1996

Y1 - 1996

N2 - New neuroleptic drugs are being developed for the treatment of schizophrenia and other psychoses. Clozapine and risperidone are available for general use. Sertindole and olanzapine are nearing release. Seroquel and ziprazidone are in the final stages of study. This generation of drugs will provide advantages in the area of lower motor side effects and probably in improved negative symptom treatment.

AB - New neuroleptic drugs are being developed for the treatment of schizophrenia and other psychoses. Clozapine and risperidone are available for general use. Sertindole and olanzapine are nearing release. Seroquel and ziprazidone are in the final stages of study. This generation of drugs will provide advantages in the area of lower motor side effects and probably in improved negative symptom treatment.

KW - Clinical response

KW - Neuroleptics

KW - New antipsychotics

KW - Olanzapine

KW - Seroquel

KW - Sertindole

KW - Ziprazidone

UR - http://www.scopus.com/inward/record.url?scp=0029890025&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029890025&partnerID=8YFLogxK

U2 - 10.1097/00004850-199605002-00012

DO - 10.1097/00004850-199605002-00012

M3 - Article

C2 - 8803664

AN - SCOPUS:0029890025

SN - 0268-1315

VL - 11

SP - 73

EP - 76

JO - International Clinical Psychopharmacology

JF - International Clinical Psychopharmacology

IS - SUPPL. 2

ER -

The new generation of antipsychotic drugs

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this